Wealth Enhancement Advisory Services’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$493K Buy
12,691
+2,271
+22% +$73.4K ﹤0.01% 2701
2026
Q1
$363K Sell
10,420
-5,174
-33% -$166K ﹤0.01% 2601
2025
Q4
$504K Buy
15,594
+701
+5% +$24.8K ﹤0.01% 2475
2025
Q3
$470K Buy
14,893
+5,900
+66% +$176K ﹤0.01% 2416
2025
Q2
$254K Buy
+8,993
New +$237K ﹤0.01% 2784
2025
Q1
Sell
-10,117
Closed -$407K 3177
2024
Q4
$407K Sell
10,117
-15,598
-61% -$889K ﹤0.01% 2140
2024
Q3
$1.63M Buy
25,715
+9,965
+63% +$585K ﹤0.01% 1157
2024
Q2
$835K Buy
15,750
+8,344
+113% +$547K ﹤0.01% 1364
2024
Q1
$607K Buy
+7,406
New +$330K ﹤0.01% 1470

Other funds holding VKTX